Cite
HARVARD Citation
Zehentmayr, F. et al. (2016). Hsa-miR-375 is a predictor of local control in early stage breast cancer. Clinical epigenetics. 8 (1), pp. 1-13. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zehentmayr, F. et al. (2016). Hsa-miR-375 is a predictor of local control in early stage breast cancer. Clinical epigenetics. 8 (1), pp. 1-13. [Online].